Practice Management

The AstraZeneca novel coronavirus (COVID-19) vaccine candidate, AZD1222, demonstrated 79 percent efficacy at preventing symptomatic COVID-19 and 100

The Integrative Healthcare Symposium event organizers announced new dates for its 2021 edition of the in-person conference, produced by Diversified

Fully vaccinated individuals can visit each other mask-free, according to the latest guidance from the U.S. Centers for Disease Control and

The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have the novel coronavirus (COVID-19),

The U.S. Food and Drug Administration (FDA) issued late last week an emergency use authorization for the third novel coronavirus (COVID-19)

Racism and discrimination exist prominently in healthcare. Racial disparities in medicine are not only the result of individual actions, but of

The United States will have enough supply of the novel coronavirus (COVID-19) vaccination to cover 300 million Americans by the end of July,

Johnson and Johnson submitted an application to the U.S. Food and Drug Administration (FDA) on Thursday, requesting emergency use authorization for